Back
ESC Premium Access

Clinical acceptability of trimetazidine 80 mg once daily versus trimetazidine modified release 35 mg twice daily in chronic stable angina pectoris

Session: Poster session 2 - Stable angina - Treatment and outcomes
Topic: Angina pectoris stable
Speaker: Professor Y. Pozdnyakov (Zhukovsky, RU)
Event: ESC Congress 2016

Congress Presentation

About the speaker

Professor Yuri Pozdnyakov

Moscow Regional Cardiology Center, Zhukovsky (Russian Federation)
0 follower

23 more presentations in this session

Statins for the prevention of early postoperative cognitive dysfunction in patients undergoing coronary artery bypass grafting

Speaker: Doctor O. Maleva (Kemerovo, RU)

Access
Abstract
Thumbnail

Temporal trends in management and long-term prognosis of patients with stable angina between 2006 and 2012

Speaker: Professor M. Gasior (Zabrze, PL)

Access
Abstract
Thumbnail

Early vascular responses to everolimus-eluting cobalt-chromium stent for the treatment of stable coronary artery disease: The results of MECHANISM-Elective 1 and 3 months OCT follow-up cohort

Speaker: Professor T. Shinke (Tokyo, JP)

Access
Abstract
Slides
Thumbnail

In stable patients with suspected coronary artery disease the concentrations of high sensitive troponin I are related to the clinical angina classification

Speaker: Miss D. Madsen (Odense, DK)

Access
Abstract
Slides
Thumbnail

Five-year clinical outcomes in patients with moderate coronary artery spasm as assessed by intracoronary acetylcholine provocation test

Speaker: Professor Y. Kim (Chuncheon, KR)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster session 2 - Stable angina - Treatment and outcomes

Speakers: Professor Y. Pozdnyakov, Doctor O. Maleva, Professor M. Gasior, Professor T. Shinke, Miss D. Madsen...
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb